4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-20-008166
EVP, North America Commercial sold 4,799 shares at $12.27 ($58,884)
- EVP, North America Commercial acquired 16,120 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
O'Grady Brendan P. · EVP, North America Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-09 | Exercise or conversion : show line 1 in the form | +16,120 | 18,255.49 | D | ||
| 2020-02-10 | Sale : show line 2 in the form | −4,799 | $12.27 | $58,884 | 13,456.49 | D |
| Open-market sales · 4,799 sh · avg $12.27 · $58,884 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-09 | Exercise or conversion : show line 3 in the form Restricted Share Units | −16,120 | 32,241 | D |
Loading xslF345X03/doc4.xml…